Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.
Amer Zeidan, MBBS, MHS: Myelodysplastic syndromes [MDS] have, for a long time, been a disease entity that’s difficult to understand. There are misconceptions out there about myelodysplastic syndromes ...
Ryan Haumschild, PharmD, MS, MBA: Hello, and welcome to this AJMC® Peer Exchange program titled “Updates in the Management of Myelodysplastic Syndromes.” I’m Dr Ryan Haumschild, the director of ...
Myelodysplastic syndromes, also called myelodysplasia or MDS, is the name for a group of conditions that cause the number of normal blood cells to drop. In these syndromes, the bone marrow does not ...
Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN ...
Please provide your email address to receive an email when new articles are posted on . Olutasidenib monotherapy or combination therapy may help certain patients with myelodysplastic syndrome achieve ...
DUBLIN--(BUSINESS WIRE)--The "Myelodysplastic Syndromes: Opportunity Analysis and Forecasts to 2028" report has been added to ResearchAndMarkets.com's offering. The greatest drivers of growth in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback